Flamel Technologies S.A. (ADR) (NASDAQ:FLML)

CAPS Rating: 5 out of 5

A biopharmaceutical company principally engaged in the development of two unique polymer-based drug delivery technologies for the improvement of medical applications.

Recs

0
Player Avatar face2thehighfog (79.37) Submitted: 9/18/2009 10:38:47 AM : Outperform Start Price: $9.55 FLML Score: -77.90

nano!

Featured Broker Partners


Advertisement